Authorized QIAGEN Distributor in Nepal · JHS Analytic Traders
QIAGEN QIAstat-Dx.
One closed cartridge. Multiplex syndromic results in a single run.
Automated, closed-cartridge, real-time multiplex PCR for clinical syndromic infection testing. CE-IVD marked. Respiratory, gastrointestinal, and meningitis/encephalitis panels.
One closed disposable cartridge integrates the entire molecular workflow — sample preparation, nucleic acid extraction, real-time PCR amplification, and fluorescence detection. A single cartridge tests multiple pathogens simultaneously from one patient sample, in a single closed run, with no pre-PCR / post-PCR room separation required. The QIAstat-Dx Analyzer runs the cartridges via a touch-screen interface, supports modular stacking, and offers bidirectional LIS connectivity. CE-IVD marked. Refer to QIAGEN for current panel target lists and run-time specifications.
Three syndromic categories — one platform
Each panel is a separate cartridge; one Analyzer runs all panels. Cartridges sold separately, ordered per assay.
Respiratory Panel Plus
Multiplex detection of viral, atypical bacterial, and emerging respiratory pathogens from a single nasopharyngeal swab.
Covers common respiratory viruses (including SARS-CoV-2, Influenza, RSV) and atypical bacterial pathogens — refer to QIAGEN for the current Respiratory Panel Plus target list.
Gastrointestinal Panel 2
Multiplex bacterial, viral, and parasitic enteric targets responsible for acute infectious diarrhoea — from a single stool sample.
Covers common enteric bacterial, viral, and parasitic pathogens (e.g. Salmonella, Norovirus, Giardia) — refer to QIAGEN for the current Gastrointestinal Panel 2 target list.
Meningitis / Encephalitis Panel
Multiplex bacterial and viral causes of community-acquired meningitis and encephalitis — from CSF, in the same shift the lumbar puncture is performed.
Covers common CSF bacterial and viral pathogens (e.g. S. pneumoniae, N. meningitidis, Enterovirus) — refer to QIAGEN for the current Meningitis / Encephalitis Panel target list.
Specific cartridge availability and regulatory status (CE-IVD / FDA) vary by region. JHS confirms current panel availability for Nepal at the quotation stage.
A mini-lab in a disposable
Each QIAstat-Dx cartridge is a self-contained closed reaction system — sample chamber, lysis & nucleic acid extraction, multiplex real-time PCR wells, and detection optics window, all sealed inside a single disposable. Wet and dry reagents are pre-loaded; no precision pipetting required between sample loading and the result.
Syndromic Point-of-Care in Nepal
Best positioned for tertiary teaching hospitals, paediatric ICUs, infection control programmes, reference labs serving multi-hospital networks, and outbreak investigation teams — the higher the febrile-illness throughput, the more clinical value the same-shift result delivers. The pathogen mix that drives ED triage and ICU admissions in Nepal (SARS-CoV-2, seasonal influenza, RSV, enteric pathogens, dengue — Nepal recorded 51,243 dengue cases in 2023 per EDCD surveillance) overlaps clinically with the cartridge panel menus. For lower-volume community settings, point-of-care platforms like Cowin Gene NATBox are typically the better fit; JHS supplies both. QIAstat-Dx is not positioned as a TB diagnostic — for TB testing, see TB Diagnostics.
Clinical settings & use cases
Emergency Department Triage
Rapid syndromic identification of febrile and respiratory illness — informs antibiotic decisions, isolation, and admission status before the patient leaves ED.
Hospital Infection Control
Rapid pathogen identification supports cohorting decisions, contact tracing, and outbreak response within tertiary hospital infection prevention programmes.
Paediatric & Adult ICU
Fast multiplex respiratory / GI / meningitis testing for critically ill patients — reduces empiric antibiotic exposure and accelerates targeted therapy.
Reference Labs
Centralised molecular testing for hospital networks — same instrument, multiple panels, scalable throughput via stackable modules.
Outbreak Investigation
Field-deployable syndromic identification during respiratory or enteric outbreaks — same-day pathogen ID supports public health response.
Paediatric Diagnostics
Single-swab, multi-pathogen workup for children with respiratory or GI symptoms — minimises invasive sampling, accelerates discharge decisions.
QIAstat-Dx is part of JHS's QIAGEN Portfolio.
Authorized QIAGEN distributor for clinical and research molecular diagnostics — delivering complete workflows from extraction to detection.
Product documentation & media
Manufacturer walkthrough showing the core workflow, instrument modularity, and key operating steps.
Which panels are available?
The principal panels are Respiratory Panel Plus (multiplex viral and bacterial respiratory pathogens including SARS-CoV-2, influenza, and RSV), Gastrointestinal Panel 2 (bacterial, viral, and parasitic enteric pathogens), and the Meningitis / Encephalitis Panel (bacterial and viral causes from CSF). Specific cartridge availability, target lists, and regulatory status vary by region and by panel revision — JHS confirms current QIAGEN panel availability and the target list for Nepal at the quotation stage.
How does QIAstat-Dx differ from a conventional rt-PCR workflow?
Conventional rt-PCR labs require separate workflows for nucleic acid extraction, master mix preparation, amplification, and detection — typically across two or three rooms with strict workflow segregation. QIAstat-Dx integrates all of these steps inside a single closed disposable cartridge: load the sample, insert the cartridge, press run. Sample-to-answer is approximately 1 hour vs 4–6 hours conventional. Multiplex detection of multiple targets in a single cartridge replaces multiple individual PCR runs.
Is QIAstat-Dx WHO-prequalified for tuberculosis testing?
No. QIAstat-Dx panels are not WHO-prequalified for TB diagnosis. The only rapid molecular TB tests with WHO prequalification are dedicated TB platforms from other manufacturers. QIAstat-Dx is positioned for syndromic infection testing — respiratory, GI, and meningitis/encephalitis — rather than TB-specific diagnostics.
Does JHS supply QIAstat-Dx and its panel cartridges?
Yes. As QIAGEN's authorized distributor in Nepal, JHS supplies the QIAstat-Dx Analyzer and panel cartridges through manufacturer-authorized channels. Service scope, training, validation documentation, LIS integration, and warranty terms are confirmed at quotation per project to match your lab's requirements.